Matches in Wikidata for { <http://www.wikidata.org/entity/Q37162650> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q37162650 description "article científic" @default.
- Q37162650 description "article scientifique" @default.
- Q37162650 description "articolo scientifico" @default.
- Q37162650 description "artigo científico" @default.
- Q37162650 description "artículu científicu espublizáu en 2011" @default.
- Q37162650 description "bilimsel makale" @default.
- Q37162650 description "scientific article published on April 2011" @default.
- Q37162650 description "vedecký článok" @default.
- Q37162650 description "vetenskaplig artikel" @default.
- Q37162650 description "videnskabelig artikel" @default.
- Q37162650 description "vědecký článek" @default.
- Q37162650 description "wetenschappelijk artikel" @default.
- Q37162650 description "wissenschaftlicher Artikel" @default.
- Q37162650 description "наукова стаття, опублікована у квітні 2011" @default.
- Q37162650 description "научни чланак" @default.
- Q37162650 description "مقالة علمية نشرت في أبريل 2011" @default.
- Q37162650 name "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 name "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 name "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 type Item @default.
- Q37162650 label "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 label "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 label "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 prefLabel "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 prefLabel "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 prefLabel "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 P1433 Q37162650-CBC8E274-BF88-4FC2-AB88-E11B0655AEF2 @default.
- Q37162650 P1476 Q37162650-6FF43A2C-3A13-4AA5-8BC9-F2F6163B2539 @default.
- Q37162650 P2860 Q37162650-22D98557-E53B-444E-A5D7-56B90C684B14 @default.
- Q37162650 P2860 Q37162650-3C28681A-C533-478D-B00C-E4904B1D4467 @default.
- Q37162650 P2860 Q37162650-6073578E-BC8D-4768-AC5F-290A9D42128F @default.
- Q37162650 P2860 Q37162650-767715E4-7808-4B3B-B196-6995877788C6 @default.
- Q37162650 P2860 Q37162650-97C5F5B8-BAAF-409B-8F6F-0478F90B56D7 @default.
- Q37162650 P2860 Q37162650-B7328622-E656-4753-B432-5D6BED8995AF @default.
- Q37162650 P2860 Q37162650-E5D0CA23-33FD-4DAD-AC96-53A7DA6E6851 @default.
- Q37162650 P2888 Q37162650-21504BF0-87F7-4001-99AD-4C0640AF824A @default.
- Q37162650 P304 Q37162650-872EAE31-B254-43A7-8D6D-D447870BF64F @default.
- Q37162650 P31 Q37162650-F6C1F2E0-4F86-40E7-A2C8-AFC6425683E2 @default.
- Q37162650 P356 Q37162650-16BFAC0C-917B-4E4E-A91A-0F34FF95700E @default.
- Q37162650 P433 Q37162650-2E674D0D-1D5E-42B5-9786-7CFE440696D8 @default.
- Q37162650 P478 Q37162650-E99C9E83-F985-41EF-B8A3-A9C9A435050F @default.
- Q37162650 P50 Q37162650-E9F0948B-E4C1-45BE-A202-162EF67C44EB @default.
- Q37162650 P577 Q37162650-B6CDD7D5-53A7-45D7-A115-06F35388EA40 @default.
- Q37162650 P698 Q37162650-BD52EA3D-4A33-4000-9FAC-E0BFBBDA535F @default.
- Q37162650 P921 Q37162650-5AC14C0C-733F-4CD3-9988-58CDC683980D @default.
- Q37162650 P921 Q37162650-EC2186F4-847D-4208-AA57-E49496FF770E @default.
- Q37162650 P932 Q37162650-ECD5C6A8-5EE2-4905-AE6F-3D68365E5DA3 @default.
- Q37162650 P356 S12170-011-0159-3 @default.
- Q37162650 P698 24040425 @default.
- Q37162650 P1433 Q27723050 @default.
- Q37162650 P1476 "Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study" @default.
- Q37162650 P2860 Q28259638 @default.
- Q37162650 P2860 Q28308033 @default.
- Q37162650 P2860 Q29619609 @default.
- Q37162650 P2860 Q29619614 @default.
- Q37162650 P2860 Q37193386 @default.
- Q37162650 P2860 Q37734553 @default.
- Q37162650 P2860 Q42562376 @default.
- Q37162650 P2888 s12170-011-0159-3 @default.
- Q37162650 P304 "109-112" @default.
- Q37162650 P31 Q13442814 @default.
- Q37162650 P356 "10.1007/S12170-011-0159-3" @default.
- Q37162650 P433 "2" @default.
- Q37162650 P478 "5" @default.
- Q37162650 P50 Q87075032 @default.
- Q37162650 P577 "2011-04-01T00:00:00Z" @default.
- Q37162650 P698 "24040425" @default.
- Q37162650 P921 Q190805 @default.
- Q37162650 P921 Q844935 @default.
- Q37162650 P932 "3769953" @default.